Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
Clinical trial NCT03614689 · UNKNOWN
Trial details
- NCT number
- NCT03614689
- Sponsor
- Geneplus-Beijing Co. Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-25
- Primary completion
- 2020-11-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.